ID   ACC-LC-172/CDDP
AC   CVCL_Y202
SY   SK3/CDDP
DR   cancercelllines; CVCL_Y202
DR   Wikidata; Q54608105
RX   PubMed=2547517;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7005 ! ACC-LC-172
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
RX   PubMed=2547517;
RA   Hida T., Ueda R., Takahashi T., Watanabe H., Kato T., Suyama M.,
RA   Sugiura T., Ariyoshi Y., Takahashi T.;
RT   "Chemosensitivity and radiosensitivity of small cell lung cancer cell
RT   lines studied by a newly developed
RT   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
RT   hybrid assay.";
RL   Cancer Res. 49:4785-4790(1989).
//
RX   PubMed=8384671; DOI=10.1093/oxfordjournals.jjco.a039602;
RA   Hida T., Ariyoshi Y., Kuwabara M., Sugiura T., Takahashi T.,
RA   Takahashi T., Hosoda K., Niitsu Y., Ueda R.;
RT   "Glutathione S-transferase pi levels in a panel of lung cancer cell
RT   lines and its relation to chemo-radiosensitivity.";
RL   Jpn. J. Clin. Oncol. 23:14-19(1993).
//